We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Tags

Firm name

Author

1,411 results found

Article

Bass, Berry & Sims PLC | USA | 2 Aug 2019

Key Takeaways from CMS’ New Proposed Rule on Stark Law Advisory Opinions

While the industry awaits more sweeping value-based related changes to the Stark Law regulations, on July 29, 2019, the Centers for Medicare &

Article

Blank Rome LLP | USA, Canada | 1 Aug 2019

Will HHS’s Safe Importation Action Plan Affect How the Federal Government Purchases Drugs?

On July 31, the Department of Health and Human Services (“HHS”) and the Food and Drug Administration (“FDA”) announced their

Article

Sheppard Mullin Richter & Hampton LLP | USA | 25 Jul 2019

Is Prescription Drug Pricing The Cure For Partisanship?

In a rare act of bipartisanship, Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., introduced on July

Article

Manatt Phelps & Phillips LLP | USA | 22 Jul 2019

Healthcare Price Transparency: Implications for Providers and Payers

On June 24, 2019, President Donald Trump issued an “Executive Order on Improving Price and Quality Transparency in American Healthcare to Put

Article

Quarles & Brady LLP | USA | 9 Jul 2019

340B Litigation Updates and Other Program Developments

In the latest development of the ongoing 340B Medicare Part B payment reduction controversy, US District Judge Rudolph Contreras again concluded that

Article

Morgan Lewis | USA | 2 Jul 2019

Will Hospitals and Insurers Have to Disclose Their Contracted Rates to Consumers Under Executive Order?

US President Donald Trump issued the Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First on June

Article

Manatt Phelps & Phillips LLP | USA | 25 Jun 2019

The Final Rule’s Impact on Drug Pricing Transparency

On May 8, the administration issued the much-anticipated final rule requiring drug manufacturers to disclose wholesale acquisition prices in their

Article

Brownstein Hyatt Farber Schreck LLP | USA | 21 Jun 2019

Medicare Rulemaking After Azar v. Allina Health Services

The Medicare Program, established in 1965, initially seemed simple: provide health care for senior citizens by paying hospitals and doctors directly

Article

FisherBroyles LLP | USA | 18 Jun 2019

Chiedi Takes Over as HHS Inspector General - Promises Aggressive Enforcement

On June 1, Joanne Chiedi assumed the role of Acting Inspector General at the U.S. Department of Health and Human Services following the departure of

Article

McGuireWoods Consulting LLC | USA | 10 Jun 2019

Supreme Court Rules HHS Cannot Take Short-Cuts in Rulemaking

In a 7-to-1 decision, the U.S. Supreme Court on June 3, 2019, held that “Because the Department of Health and Human Services neglected its statutory

Previous page 1 2 3 ...